$7.000
-0.260 (-3.71%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
TRDA Prediction & Forecast by Similar Chart Analysis
Alphio's TRDA stock price prediction model matches the current Entrada Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $6.86 (-2.05%). The 1-week path is $6.87 (-1.83%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Entrada Therapeutics Inc Stock?
Entrada Therapeutics Inc is currently not a strong buy due to its high net losses and declining collaboration revenue, despite a recent narrower loss of $42.76 million in Q2 2026. The current price is $7, which is significantly lower than the analyst price target of $11, indicating potential upside. However, the RSI is at 40.012, suggesting it is nearing oversold territory, but the negative trend in insider selling (up 1842.13%) raises concerns about confidence in the stock.
TRDA stock price ended at $7.00 on Friday, after losing -3.71%
Entrada Therapeutics Inc (TRDA) last closed at $7, losing -3.71%. These facts feed the 1-day and 1-week TRDA price prediction above.
Forecast Drivers
Entrada Therapeutics Inc (TRDA) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches TRDA, ranked by similarity.
Seasonality analysis for TRDA
Historically the probability of a positive August return for TRDA is 23.81%. November offers the highest probability of a positive month at 51.28%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for TRDA
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $4.00 | $4.01 | $4.35 | -42.66% |
| Sep 2026 | $4.26 | $5.06 | $6.08 | -27.77% |
| Oct 2026 | $3.01 | $3.76 | $4.25 | -46.25% |
| Nov 2026 | $3.17 | $3.97 | $4.59 | -43.27% |
| Dec 2026 | $3.50 | $3.76 | $4.40 | -46.25% |
In 2026, Entrada Therapeutics Inc (TRDA) is projected to range from $3.01 to $6.08.
Entrada Therapeutics Inc 2026 monthly forecast
In Aug 2026, Entrada Therapeutics Inc is projected to average $4.01, with a low of $4.00 and high of $4.35.
In Sep 2026, Entrada Therapeutics Inc is projected to average $5.06, with a low of $4.26 and high of $6.08.
In Oct 2026, Entrada Therapeutics Inc is projected to average $3.76, with a low of $3.01 and high of $4.25.
In Nov 2026, Entrada Therapeutics Inc is projected to average $3.97, with a low of $3.17 and high of $4.59.
In Dec 2026, Entrada Therapeutics Inc is projected to average $3.76, with a low of $3.50 and high of $4.40.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.